Home / Research library / 5-Amino-1MQ
5-Amino-1MQ: molecular data, studies & sources
5-Amino-1MQ is catalogued here as a research compound. This profile brings together the molecular source record, selected indexed publications and available supplier comparisons. Evidence for a named substance does not authenticate a commercial product.
Compiled by PeptideTech Editors · Sources checked · Selected bibliography, not a systematic review
Molecular formula, weight & structure
- Molecular formula (MF)
- C10H11N2+
- Molecular weight (MW)
- 159.21 g/mol
- PubChem compound ID
- 950107
- Record title
- 5-Amino-1-methylquinolinium
The formula and structure describe the 5-amino-1-methylquinolinium cation. Chloride and other counterions change the formula and molecular weight of a supplied salt.
Source: PubChem CID 950107 · retrieved 2026-09-21

Chemical identifiers and source data
- IUPAC name
- 1-methylquinolin-1-ium-5-amine
- InChIKey
- ZMJBCEIHNOWCMC-UHFFFAOYSA-O
- SMILES
- C[N+]1=CC=CC2=C(C=CC=C21)N
Identifiers
- PubChem CID
- 950107
- ChEMBL ID
- CHEMBL4116828
- InChIKey
- ZMJBCEIHNOWCMC-UHFFFAOYSA-O
Calculated molecular descriptors
| Monoisotopic (exact) mass | 159.0917 Da |
|---|---|
| Heavy atoms | 12 |
| Hydrogen-bond donors | 1 |
| Hydrogen-bond acceptors | 1 |
| Rotatable bonds | 0 |
| Topological polar surface area | 29.9 Ų |
| Calculated logP (Crippen) | 1.25 |
| Rings | 2 |
| Stereocenters | 0 |
| Formal charge | 1 |
Computed with RDKit from the published SMILES (Crippen logP, topological polar surface area). Calculated descriptors are not measured properties of a supplied batch.
Registered clinical trials
Studies registered on ClinicalTrials.gov that list 5-Amino-1MQ as an intervention. Studies that only measure the molecule as a biomarker, or use it only as a comparator or background arm for another drug, are excluded. A registration describes a planned or completed protocol; it does not report a result. Active studies are listed first.
No registered study naming this compound was matched. This is a documented gap in registry coverage, not proof that no study exists.
Registry check 2026-10-01 · Run this search on ClinicalTrials.gov
Human intervention studies
Selected studies in which participants received 5-Amino-1MQ, with their indexed or reviewed study type. Check the original article for the formulation, population and controls. Studies that only measured the molecule, or used it as a comparator, are listed separately below and are not counted as intervention studies.
No human study that administered this compound was retained in this selected bibliography. This is a documented evidence gap in our selection, not proof that no study exists.
Preclinical research, reviews & other publications
Animal studies, laboratory experiments, reviews and other indexed papers answer different questions. A review is secondary evidence; a case report does not estimate how often an outcome occurs.
- Preclinical / laboratory research
Reduced calorie diet combined with NNMT inhibition establishes a distinct microbiome in DIO mice.
Dimet-Wiley A, Wu Q, Wiley JT et al. · Scientific reports · 2022
PMID 35013352 · DOI: 10.1038/s41598-021-03670-5
- Preclinical / laboratory research
Nicotinamide N-methyltransferase inhibition mitigates obesity-related metabolic dysfunction.
Babula JJ, Bui D, Stevenson HL et al. · Diabetes, obesity & metabolism · 2024
PMID 39161060 · DOI: 10.1111/dom.15879
- Preclinical / laboratory research
Small molecule inhibitor of nicotinamide N-methyltransferase shows anti-proliferative activity in HeLa cells.
Akar S, Duran T, Azzawri AA et al. · Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology · 2021
PMID 33645410 · DOI: 10.1080/01443615.2020.1854696
5-Amino-1MQ supplier sources
Scientific sources describe molecules and experiments. The commercial links below identify recorded supplier packages. A publication or chemical database entry does not verify the seller, purity, sterility or contents of a lot. Some links are affiliate links; see our disclosure.
5-Amino-1MQ for sale: compare prices, sizes and forms from every tracked supplier →
| Supplier | Recorded packages | Example source listing |
|---|---|---|
| Amino ClubUSD | 50mg Vial1 recorded offers | 50mg Vial · $49.99Stale observation · Checked Sep 28, 2026Supplier listing, 5-Amino-1MQ 50mg Vial, Amino Club, opens in a new tab |
| Amino USAUSD | 50mg Vial · 50mg×60 Capsules2 recorded offers | 50mg Vial · $84.99Checked Oct 13, 2026Supplier listing, 5-Amino-1MQ 50mg Vial, Amino USA, opens in a new tab |
| Cenexa LabsUSD | 5mg Vial · 50mg Vial · 10mg Vial3 recorded offers | 5mg Vial · $54.99Checked Oct 12, 2026Supplier listing, 5-Amino-1MQ 5mg Vial, Cenexa Labs, opens in a new tab |
| American PeptidesUSD | 50mg Vial1 recorded offers | 50mg Vial · $80.00Recorded out of stock · Checked Oct 13, 2026Supplier listing, 5-Amino-1MQ 50mg Vial, American Peptides, opens in a new tab |
Reference sources & further reading
- PubChem compound record 950107 — chemical identity and structure.
The citations above link directly to publication records. Encyclopedia links are background reading and are not used to establish clinical effectiveness.
Search for additional research
These links run searches; their results have not been individually reviewed and can include unrelated compounds.
Research information is not a dosing guide or a recommendation for personal use. Study findings are specific to the formulation, population and methods tested. Read our source and correction policy.
Related research profiles
FOXO4-DRI
C228H388N86O64
5358 g/mol · PubChem CID 167312269
4 selected publications · 0 human intervention studies
GHK-Cu
C14H23CuN6O4+
402.92 g/mol · PubChem CID 71587328
1 selected publication · 0 human intervention studies · 1 registered trial
Glutathione
C10H17N3O6S
307.33 g/mol · PubChem CID 124886
7 selected publications · 3 human intervention studies · 37 registered trials
Small molecule · highest stage: Phase 3
Humanin
C119H204N34O32S2
2687.2 g/mol · PubChem CID 16131438
1 selected publication · 0 human intervention studies
L-Carnitine
C7H15NO3
161.20 g/mol · PubChem CID 10917
8 selected publications · 0 human intervention studies · 40 registered trials
Small molecule · highest stage: Approved in at least one jurisdiction (ChEMBL phase 4)
MOTS-c
C101H152N28O22S2
2174.6 g/mol · PubChem CID 146675088
6 selected publications · 0 human intervention studies · 1 registered trial